Cybrexa Therapeutics Announces New Preclinical Data on Tumor-Selective Peptide-Drug Conjugates at ESMO Targeted Anticancer Therapies Congress 2025
(PDCs) demonstrate tumor-selective delivery and potent anticancer activityPreclinical data show robust efficacy ...
Yahoo Finance25d
AVEO Oncology, an LG Chem company, Presents Two Posters for Tivozanib at the 2025 ASCO GU Meeting
Aveo Oncology Logo (PRNewsfoto/AVEO, an LG Chem company) "Following the TiNivo-2 study results presentation at ESMO 2024 and publication ... RCC population." Poster title: "Integrated efficacy ...